Phospholipid-based nanolipid carriers for dual kinase inhibitors in triple-negative breast cancer
Nabil K. Alruwaili(Jouf University), Mahfoozur Rahman(Sam Higginbottom Institute of Agriculture), Salem Salman Almujri(King Khalid University), Waleed Hassan Almalki(Umm al-Qura University), Abdulaziz Alzahrani(Al Baha University), Majed Alrobaian(Taif University), Md. Abul Barkat(University of Hafr Al-Batin), Tanuja Singh(Jamia Millia Islamia), Anjali Singh(Ford Hospital and Research Centre), Abdulrahman Alhamyani(University of Louisiana at Monroe), Abdulkareem A. Alanezi(University of Hafr Al-Batin), Esraa M. Haji(University of Hafr Al-Batin), Alhussain Aodah(Prince Sattam Bin Abdulaziz University)
Cited by 0
Related Papers
The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review
|International Journal of Biological Macromolecules|2023|174
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
|International Journal of Biological Macromolecules|2023|125
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer
|Pathology - Research and Practice|2023|111
MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
|Pathology - Research and Practice|2023|110
Polysaccharide-Based Nanomedicines Targeting Lung Cancer
|Pharmaceutics|2022|89